Mark Corrigan - 07 Aug 2023 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Director
Signature
/s/ Mark Corrigan
Issuer symbol
WVE
Transactions as of
07 Aug 2023
Net transactions value
$0
Form type
4
Filing time
09 Aug 2023, 20:00:21 UTC
Previous filing
20 Jul 2023
Next filing
14 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +45,000 $0.000000 45,000 07 Aug 2023 Ordinary Shares 45,000 $4.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2024 annual general meeting or August 7, 2024.